肥胖症手术与低能量饮食对体成分和组织特异性葡萄糖摄取的短期影响:一项使用全身集成18F-FDG-PET/MRI的随机临床研究
这项平行组随机对照试验将等待肥胖症手术的患者随机分配至直接手术组或术前低能量饮食组,4周后比较体成分、血糖控制和胰岛素敏感性。手术组HOMA-IR显著降低26.3%,而低能量饮食组降低20.9%未达统计学显著;仅手术组空腹血糖和胰岛素显著降低,且仅手术组显示骨骼肌葡萄糖摄取率显著增加而心脏和腹部脂肪组织摄取减少。作者认为手术的短期代谢效应不能仅用体脂减少解释,且全身胰岛素抵抗和血糖的完全效应需要超过4周的时间。
要点
- 肥胖症手术4周后HOMA-IR显著降低26.3%(95%CI -49.5至-3.0,p=0.009),低能量饮食组降低20.9%未达统计学显著。
- 仅手术组空腹血糖和胰岛素显著降低,且仅手术组骨骼肌PET葡萄糖摄取率显著增加、心脏和腹部脂肪组织摄取减少。
- 两种干预均使体重、脂肪组织体积和肝脂肪含量出现相似降低,但手术的短期代谢效应不能仅由体脂减少解释。
核心结论
- 肥胖症手术4周后的短期代谢效应不能仅用体脂减少解释。
- 手术而非低能量饮食导致空腹血糖和胰岛素抵抗降低,并使胰岛素刺激的葡萄糖流向不同组织发生明显变化,这些效应可能有助于预防或逆转2型糖尿病。
- 全身胰岛素抵抗和血糖的完全效应需要超过4周的时间。
研究设计与样本
- 平行组随机对照试验,等待肥胖症手术的患者随机(非盲法,密封信封)分配至直接手术组或术前低能量饮食组。
- 在基线和术后4周(n=15,11例Roux-en-Y胃旁路术和4例袖状胃切除术)或低能量饮食开始后4周(n=9)进行检查,包括OGTT和高胰岛素-正常血糖钳夹,同时进行全身[18F]氟脱氧葡萄糖-正电子发射断层扫描(PET)/MRI。
- 主要结局为HOMA-IR变化。
主要发现
- 术后1个月和低能量饮食开始后,两种治疗均引起相似的体重降低(均值±SD:-7.7±1.4 kg和-7.4±2.2 kg)、脂肪组织体积降低(7%)和肝脂肪含量降低(2%单位)。
- HOMA-IR在肥胖症手术后显著降低(-26.3% [95%CI -49.5, -3.0],p=0.009),在低能量饮食后非显著降低(-20.9% [95%CI -58.2, 16.5])。
- 两组甘油三酯和LDL胆固醇降低相似;空腹血糖和胰岛素仅在肥胖症手术后显著降低。
- OGTT后葡萄糖AUC在肥胖症手术组增加(20%),低能量饮食组未增加;高胰岛素血症期间仅手术组显示骨骼肌PET葡萄糖摄取率显著增加,但心脏和腹部脂肪组织摄取减少。
- 肝脏和脑葡萄糖摄取率在手术或低能量饮食后均无变化;全身葡萄糖处置和内源性葡萄糖生成未受显著影响。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Obesity surgery (OS) and diet-induced weight loss rapidly improve insulin resistance. We aim to investigate the impact of either Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) surgery compared with a diet low in energy (low-calorie diet; LCD) on body composition, glucose control and insulin sensitivity, assessed both at the global and tissue-specific level in individuals with obesity but not diabetes. METHODS: In this parallel group randomised controlled trial, patients on a waiting list for OS were randomised (no blinding, sealed envelopes) to either undergo surgery directly or undergo an LCD before surgery. At baseline and 4 weeks after surgery (n=15, 11 RYGB and 4 SG) or 4 weeks after the start of LCD (n=9), investigations were carried out, including an OGTT and hyperinsulinaemic-euglycaemic clamps during which concomitant simultaneous whole-body [18F]fluorodeoxyglucose-positron emission tomography (PET)/MRI was performed. The primary outcome was HOMA-IR change. RESULTS: One month after bariatric surgery and initiation of LCD, both treatments induced similar reductions in body weight (mean ± SD: -7.7±1.4 kg and -7.4±2.2 kg, respectively), adipose tissue volume (7%) and liver fat content (2% units). HOMA-IR, a main endpoint, was significantly reduced following OS (-26.3% [95% CI -49.5, -3.0], p=0.009) and non-significantly following LCD (-20.9% [95% CI -58.2, 16.5). For both groups, there were similar reductions in triglycerides and LDL-cholesterol. Fasting plasma glucose and insulin were also significantly reduced only following OS. There was an increase in glucose AUC in response to an OGTT in the OS group (by 20%) but not in the LCD group. During hyperinsulinaemia, only the OS group showed a significantly increased PET-derived glucose uptake rate in skeletal muscle but a reduced uptake in the heart and abdominal adipose tissue. Both liver and brain glucose uptake rates were unchanged after surgery or LCD. Whole-body glucose disposal and endogenous glucose production were not significantly affected. CONCLUSIONS/INTERPRETATION: The short-term metabolic effects seen 4 weeks after OS are not explained by loss of body fat alone. Thus OS, but not LCD, led to reductions in fasting plasma glucose and insulin resistance as well as to distinct changes in insulin-stimulated glucose fluxes to different tissues. Such effects may contribute to the prevention or reversal of type 2 diabetes following OS. Moreover, the full effects on whole-body insulin resistance and plasma glucose require a longer time than 4 weeks. TRIAL REGISTRATION: ClinicalTrials.gov NCT02988011 FUNDING: This work was supported by AstraZeneca R&D, the Swedish Diabetes Foundation, the European Union's Horizon Europe Research project PAS GRAS, the European Commission via the Marie Sklodowska Curie Innovative Training Network TREATMENT, EXODIAB, the Family Ernfors Foundation, the P.O. Zetterling Foundation, Novo Nordisk Foundation, the Agnes and Mac Rudberg Foundation and the Uppsala University Hospital ALF grants.
引用
- Eriksson JW, Pereira MJ, Kagios C, et al. Short-term effects of obesity surgery versus low-energy diet on body composition and tissue-specific glucose uptake: a randomised clinical study using whole-body integrated 18F-FDG-PET/MRI. Diabetologia. 2024. PMID: 38656372. doi:10.1007/s00125-024-06150-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。